QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
NASDAQ:VRAY

ViewRay - VRAY Stock Forecast, Price & News

$4.76
+0.17 (+3.70%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$4.61
$4.79
50-Day Range
$4.27
$4.82
52-Week Range
$2.39
$4.96
Volume
1.23 million shs
Average Volume
1.10 million shs
Market Capitalization
$863.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.33

ViewRay MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
33.1% Upside
$6.33 Price Target
Short Interest
Bearish
3.92% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.49
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Acquiring Shares
$117,500 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.60) to ($0.57) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars

Medical Sector

222nd out of 1,030 stocks

Electromedical Equipment Industry

5th out of 24 stocks


VRAY stock logo

About ViewRay (NASDAQ:VRAY) Stock

ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. It develops MRIdian to address the limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that defines the tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova in 2004 and is headquartered in Oakwood Village, OH.

Receive VRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ViewRay and its competitors with MarketBeat's FREE daily newsletter.

VRAY Stock News Headlines

The Biggest "Missing Ingredient" in the $7 Trillion EV Market
China has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market.
The Biggest "Missing Ingredient" in the $7 Trillion EV Market
China has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market.
ViewRay to host Investor Day
See More Headlines
Receive VRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ViewRay and its competitors with MarketBeat's FREE daily newsletter.

VRAY Company Calendar

Last Earnings
11/04/2021
Today
2/02/2023
Next Earnings (Confirmed)
2/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:VRAY
Employees
267
Year Founded
2004

Price Target and Rating

Average Stock Price Forecast
$6.33
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$5.50
Forecasted Upside/Downside
+33.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-110,050,000.00
Net Margins
-121.25%
Pretax Margin
-121.25%

Debt

Sales & Book Value

Annual Sales
$70.12 million
Book Value
$1.03 per share

Miscellaneous

Free Float
176,881,000
Market Cap
$863.56 million
Optionable
Optionable
Beta
1.01

Social Links


Key Executives

  • Scott William DrakeScott William Drake
    President, Chief Executive Officer & Director
  • William Patrick Burke
    Chief Financial Officer & Executive Vice President
  • James F. Dempsey
    Chief Scientific Officer
  • Martin Fuss
    Chief Medical Officer
  • Robert S. McCormack
    Secretary, Senior VP & General Counsel













VRAY Stock - Frequently Asked Questions

Should I buy or sell ViewRay stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ViewRay in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" VRAY shares.
View VRAY analyst ratings
or view top-rated stocks.

What is ViewRay's stock price forecast for 2023?

4 analysts have issued 1-year target prices for ViewRay's stock. Their VRAY share price forecasts range from $5.50 to $7.00. On average, they anticipate the company's share price to reach $6.33 in the next twelve months. This suggests a possible upside of 33.1% from the stock's current price.
View analysts price targets for VRAY
or view top-rated stocks among Wall Street analysts.

How have VRAY shares performed in 2023?

ViewRay's stock was trading at $4.48 at the start of the year. Since then, VRAY shares have increased by 6.2% and is now trading at $4.76.
View the best growth stocks for 2023 here
.

When is ViewRay's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our VRAY earnings forecast
.

How can I listen to ViewRay's earnings call?

ViewRay will be holding an earnings conference call on Monday, February 27th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were ViewRay's earnings last quarter?

ViewRay, Inc. (NASDAQ:VRAY) issued its earnings results on Thursday, November, 4th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.16) by $0.01. The company earned $19.18 million during the quarter, compared to analysts' expectations of $17.05 million. ViewRay had a negative trailing twelve-month return on equity of 78.03% and a negative net margin of 121.25%. The firm's revenue for the quarter was up 90.1% compared to the same quarter last year. During the same quarter last year, the company posted ($0.19) EPS.

What guidance has ViewRay issued on next quarter's earnings?

ViewRay updated its FY 2022 earnings guidance on Monday, January, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $102.00 million-$102.00 million, compared to the consensus revenue estimate of $100.17 million.

What is Scott Drake's approval rating as ViewRay's CEO?

5 employees have rated ViewRay Chief Executive Officer Scott Drake on Glassdoor.com. Scott Drake has an approval rating of 59% among the company's employees. This puts Scott Drake in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of ViewRay own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ViewRay investors own include Alibaba Group (BABA), Amarin (AMRN), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Verastem (VSTM), Corbus Pharmaceuticals (CRBP), Viking Therapeutics (VKTX), AbbVie (ABBV), Accuray (ARAY) and Selecta Biosciences (SELB).

When did ViewRay IPO?

(VRAY) raised $52 million in an IPO on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel acted as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

What is ViewRay's stock symbol?

ViewRay trades on the NASDAQ under the ticker symbol "VRAY."

Who are ViewRay's major shareholders?

ViewRay's stock is owned by many different institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.81%), Simplex Trading LLC (0.00%), Peregrine Capital Management LLC (0.64%), New York State Common Retirement Fund (0.40%), Legato Capital Management LLC (0.15%) and Assenagon Asset Management S.A. (0.14%). Insiders that own company stock include Brian K Roberts, Caley Castelein, Influence Ltd Strong, International Ltd Fosun, Scott William Drake, Susan C Schnabel and Zachary William Stassen.
View institutional ownership trends
.

How do I buy shares of ViewRay?

Shares of VRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ViewRay's stock price today?

One share of VRAY stock can currently be purchased for approximately $4.76.

How much money does ViewRay make?

ViewRay (NASDAQ:VRAY) has a market capitalization of $863.56 million and generates $70.12 million in revenue each year. The company earns $-110,050,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis.

How many employees does ViewRay have?

The company employs 267 workers across the globe.

Does ViewRay have any subsidiaries?
The following companies are subsidiares of ViewRay: Vesuvius Acquisition Corp., ViewRay GmbH, and ViewRay Technologies Inc..
Read More
How can I contact ViewRay?

ViewRay's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The official website for the company is www.viewray.com. The company can be reached via phone at (440) 703-3210, via email at investors@viewray.com, or via fax at 800-417-3459.

This page (NASDAQ:VRAY) was last updated on 2/2/2023 by MarketBeat.com Staff